• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Veterinary Center Receives Funding for NIH Drug Screening Research

September 22, 2006

STILLWATER, OK - 9/22/06 - The Center for Veterinary Health Sciences at Oklahoma State University was awarded an additional $2.99 million from the National Institutes of Health (NIH) in connection with the veterinary center's current NIH/National Institute of Allergy and Infectious Diseases seven-year contract.

STILLWATER, OK - 9/22/06 - The Center for Veterinary Health Sciences at Oklahoma State University was awarded an additional $2.99 million from the National Institutes of Health (NIH) in connection with the veterinary center's current NIH/National Institute of Allergy and Infectious Diseases seven-year contract. This funding, along with a recently awarded $220,724 for renovation costs, brings the total contract to $5.1 million.

The contract is for drug screening of various compounds to determine which drugs can be used to combat bioterrorism and emerging infectious disease agents. The veterinary center is one of five institutes involved in the in vitro screening part of the national program.

"What's nice about this piece of the project is that up until now, we have been concentrating mostly on testing potential bioterrorism agents," says Dr. William Barrow, professor and Sitlington Chair in Infectious Diseases in the veterinary center's Pathobiology Department. "This additional funding will allow us to move into the emerging infectious diseases arena to determine which compounds are effective against drug-resistant strains of bacteria such as staphylococci and enterococci. This will help pharmaceutical companies focus on what new drugs must be developed to protect humans from these diseases, which left untreated or uncontrolled, could be detrimental to our population."

Advertisement

According to Barrow, the funding also makes it possible to access and screen a library of 10,000 compounds. These compounds are described as drug-like, chemically diverse and well-suited for researchers who are looking for high-quality screening compounds. The collection will complement the veterinary center's existing screening collections, the university reports.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

Learning more about AmeriVet

Announcing our 2023 Fetch and Directions in Veterinary Medicine continuing education schedule: Biggest event lineup to date

Dogs and staff at Seattle dog resort safely escape fire

Pet safety for this Super Bowl Sunday

View More Latest News
Advertisement